Theravance Biopharma Stock Price History

TBPH Stock  USD 8.97  0.11  1.24%   
If you're considering investing in Theravance Stock, it is important to understand the factors that can impact its price. As of today, the current price of Theravance Biopharma stands at 8.97, as last reported on the 26th of February, with the highest price reaching 9.14 and the lowest price hitting 8.78 during the day. Theravance Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of close to zero, which indicates the firm had a close to zero % return per unit of risk over the last 3 months. Theravance Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Theravance Biopharma's Risk Adjusted Performance of (0.01), coefficient of variation of (5,255), and Variance of 6.59 to confirm the risk estimate we provide.
  
Theravance Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0074

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTBPH

Estimated Market Risk

 2.62
  actual daily
23
77% of assets are more volatile

Expected Return

 -0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Theravance Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theravance Biopharma by adding Theravance Biopharma to a well-diversified portfolio.

Theravance Biopharma Stock Price History Chart

There are several ways to analyze Theravance Stock price data. The simplest method is using a basic Theravance candlestick price chart, which shows Theravance Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 24, 202510.47
Lowest PriceJanuary 16, 20258.44

Theravance Biopharma February 26, 2025 Stock Price Synopsis

Various analyses of Theravance Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Theravance Stock. It can be used to describe the percentage change in the price of Theravance Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Theravance Stock.
Theravance Biopharma Price Daily Balance Of Power 0.31 
Theravance Biopharma Price Rate Of Daily Change 1.01 
Theravance Biopharma Accumulation Distribution 19,644 
Theravance Biopharma Price Action Indicator 0.07 

Theravance Biopharma February 26, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Theravance Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Theravance Biopharma intraday prices and daily technical indicators to check the level of noise trading in Theravance Stock and then apply it to test your longer-term investment strategies against Theravance.

Theravance Stock Price History Data

The price series of Theravance Biopharma for the period between Thu, Nov 28, 2024 and Wed, Feb 26, 2025 has a statistical range of 2.03 with a coefficient of variation of 4.45. The price distribution for the period has arithmetic mean of 9.47. The median price for the last 90 days is 9.48.
OpenHighLowCloseVolume
02/25/2025 8.84  9.14  8.78  8.97  498,732 
02/24/2025 9.30  9.40  8.84  8.86  274,365 
02/21/2025 9.74  9.74  9.27  9.32  253,974 
02/20/2025 9.71  10.05  9.61  9.66  234,075 
02/19/2025 9.47  9.76  9.47  9.75  247,900 
02/18/2025 9.70  9.88  9.41  9.47  131,964 
02/14/2025 9.51  9.65  9.40  9.61  128,499 
02/13/2025 9.45  9.60  9.27  9.48  147,103 
02/12/2025 8.91  9.40  8.90  9.36  188,238 
02/11/2025 9.08  9.49  8.85  9.04  132,304 
02/10/2025 9.39  9.53  9.11  9.12  172,746 
02/07/2025 9.51  9.56  9.28  9.30  209,660 
02/06/2025 9.73  9.76  9.33  9.51  307,609 
02/05/2025 9.55  9.80  9.55  9.72  123,953 
02/04/2025 9.44  9.54  9.39  9.43  99,090 
02/03/2025 9.25  9.59  9.23  9.47  120,031 
01/31/2025 9.68  9.68  9.27  9.38  234,929 
01/30/2025 9.63  9.76  9.59  9.67  96,279 
01/29/2025 9.79  9.79  9.46  9.63  109,140 
01/28/2025 9.67  9.88  9.60  9.83  150,224 
01/27/2025 10.46  10.46  9.62  9.67  455,047 
01/24/2025 9.65  10.90  9.62  10.47  508,066 
01/23/2025 9.26  9.68  9.24  9.67  173,993 
01/22/2025 9.10  9.45  8.94  9.36  219,253 
01/21/2025 8.62  9.19  8.61  9.15  284,522 
01/17/2025 8.53  8.59  8.41  8.58  166,562 
01/16/2025 8.62  8.62  8.35  8.44  242,283 
01/15/2025 8.67  8.86  8.61  8.61  153,845 
01/14/2025 8.61  8.70  8.46  8.53  180,211 
01/13/2025 8.76  8.76  8.55  8.57  142,329 
01/10/2025 8.99  9.05  8.68  8.78  208,167 
01/08/2025 9.25  9.38  8.99  9.05  154,996 
01/07/2025 9.19  9.35  9.04  9.25  163,890 
01/06/2025 9.30  9.44  9.14  9.19  177,429 
01/03/2025 9.30  9.56  9.29  9.31  128,403 
01/02/2025 9.46  9.46  9.23  9.28  140,930 
12/31/2024 9.48  9.55  9.34  9.41  151,981 
12/30/2024 9.61  9.72  9.44  9.47  111,213 
12/27/2024 9.82  9.91  9.54  9.59  121,239 
12/26/2024 9.80  9.92  9.73  9.86  135,661 
12/24/2024 9.82  9.89  9.72  9.85  37,942 
12/23/2024 9.59  10.00  9.53  9.79  152,704 
12/20/2024 9.65  9.83  9.56  9.59  310,234 
12/19/2024 9.68  9.90  9.63  9.73  241,837 
12/18/2024 10.00  10.08  9.62  9.71  212,954 
12/17/2024 9.78  9.99  9.65  9.96  249,829 
12/16/2024 9.87  10.06  9.77  9.80  181,109 
12/13/2024 9.84  10.00  9.74  9.88  220,768 
12/12/2024 9.94  10.11  9.74  9.87  191,136 
12/11/2024 10.08  10.10  9.96  10.04  129,668 
12/10/2024 9.97  10.15  9.94  10.08  214,765 
12/09/2024 9.89  10.25  9.89  9.99  217,550 
12/06/2024 9.81  10.01  9.81  9.88  132,468 
12/05/2024 9.58  9.88  9.55  9.84  166,283 
12/04/2024 9.84  9.98  9.55  9.59  198,084 
12/03/2024 9.45  9.84  9.37  9.84  240,477 
12/02/2024 9.14  9.53  9.14  9.44  325,663 
11/29/2024 9.46  9.49  9.20  9.25  91,398 
11/27/2024 9.32  9.56  9.25  9.42  255,336 
11/26/2024 9.50  9.50  9.20  9.24  182,269 
11/25/2024 9.52  9.76  9.47  9.47  240,130 

About Theravance Biopharma Stock history

Theravance Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Theravance is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Theravance Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Theravance Biopharma stock prices may prove useful in developing a viable investing in Theravance Biopharma
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. Theravance Biopharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. Theravance Bio is traded on NASDAQ Exchange in the United States.

Theravance Biopharma Stock Technical Analysis

Theravance Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Theravance Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Theravance Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Sign In To Macroaxis Now

   

Sign In To Macroaxis

Sign in to explore Macroaxis' wealth optimization platform and fintech modules
All  Next Launch Module

Theravance Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Theravance Biopharma's price direction in advance. Along with the technical and fundamental analysis of Theravance Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Theravance to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Theravance Stock analysis

When running Theravance Biopharma's price analysis, check to measure Theravance Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theravance Biopharma is operating at the current time. Most of Theravance Biopharma's value examination focuses on studying past and present price action to predict the probability of Theravance Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theravance Biopharma's price. Additionally, you may evaluate how the addition of Theravance Biopharma to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
CEOs Directory
Screen CEOs from public companies around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities